Literature DB >> 31017491

Analysis of risk factors of gastrointestinal stromal tumors in different age groups based on SEER database.

Xin-Yu Ge1, Li-Wang Lei1, Fei Ge1, Xian Jiang1.   

Abstract

Objective: To investigate the risk factors affecting the survival of patients with gastrointestinal stromal tumors (GISTs) in different age groups.
Methods: Information on 6089 GIST patients was screened from the Surveillance, Epidemiology, and End Results (SEER) database. Risk factor analysis was performed using a chi-square test (univariate analysis). Survival analysis was performed using the Kaplan-Meier method (log-rank test) and the COX proportional hazard model. p Value < .05 was considered statistically significant.
Results: Analyzed statistically to reveal that in addition to tumor size, mitotic index, and primary location, age, gender, race, and surgical treatment also were independent risk factors for GISTs. Gender, race, and location of disease influenced the survival rate of patients, which was higher in the young group (≤60 years old) than the elderly group (>60 years). Risk factors such as primary location, tumor diameter, and mitotic index varied significantly between the different age groups. Conclusions: Age, gender, race, and surgical treatment are independent risk factors that influence the prognosis in patients with GISTs. Some risk factors affecting prognosis are age dependent.

Entities:  

Keywords:  Gastrointestinal stromal tumors; age; prognosis; seer

Mesh:

Year:  2019        PMID: 31017491     DOI: 10.1080/00365521.2019.1604798

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  A Retrospective Study of Postoperative Outcomes in 98 Patients Diagnosed with Gastrointestinal Stromal Tumor (GIST) of the Upper, Middle, and Lower Gastrointestinal Tract Between 2009 and 2019 at a Single Center in Poland.

Authors:  Patryk Zemła; Anna Stelmach; Beata Jabłońska; Dariusz Gołka; Sławomir Mrowiec
Journal:  Med Sci Monit       Date:  2021-10-14

2.  Postoperative Adjuvant Imatinib Therapy-Associated Nomogram to Predict Overall Survival of Gastrointestinal Stromal Tumor.

Authors:  Xuechao Liu; Enyu Lin; Yuqi Sun; Xiaodong Liu; Zequn Li; Xuelong Jiao; Yi Li; Dong Guo; Peng Zhang; Xingyu Feng; Tao Chen; Zhaojian Niu; Zhiwei Zhou; Haibo Qiu; Yanbing Zhou
Journal:  Front Med (Lausanne)       Date:  2022-03-10

3.  Comparison of the Suitability Between NRS2002 and MUST as the First-Step Screening Tool for GLIM Criteria in Hospitalized Patients With GIST.

Authors:  Xin Zhou; Junjin Liu; Qijuan Zhang; Siqi Rao; Xingye Wu; Jun Zhang; Juan Li
Journal:  Front Nutr       Date:  2022-04-11

4.  Primary Localized Gastrointestinal Stromal Tumors: Medication Adherence and Prognosis According to Gender.

Authors:  Pan Ran; Juan Li; Xingye Wu; Hao Yang; Jun Zhang
Journal:  Patient Prefer Adherence       Date:  2022-08-12       Impact factor: 2.314

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.